| Document And Entity Information | Oct. 25, 2024 |
| Cover [Abstract] | |
| Amendment Flag | false |
| Entity Central Index Key | 0001826457 |
| Document Type | 8-K |
| Document Period End Date | Oct. 25, 2024 |
| Entity Registrant Name | MONTE ROSA THERAPEUTICS, INC. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-40522 |
| Entity Tax Identification Number | 84-3766197 |
| Entity Address, Address Line One | 321 Harrison Avenue |
| Entity Address, Address Line Two | Suite 900 |
| Entity Address, City or Town | Boston |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02118 |
| City Area Code | 617 |
| Local Phone Number | 949-2643 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.0001 par value per share |
| Trading Symbol | GLUE |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
